MOORESTOWN, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) announced the closing of its previously announced offering of $325 million principal amount of 1.75% convertible senior subordinated notes due 2026 (the “notes”), including the exercise by the initial purchasers of their option to purchase an additional $40 million principal amount of the notes, solely to cover over-allotments. The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

About Tabula Rasa HealthCare

TRHC (NASDAQ:TRHC) provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations.